rs1871136
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_021957.4(GYS2):c.1229+40T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.762 in 1,045,352 control chromosomes in the GnomAD database, including 304,838 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.75 ( 42625 hom., cov: 33)
Exomes 𝑓: 0.77 ( 262213 hom. )
Consequence
GYS2
NM_021957.4 intron
NM_021957.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.985
Publications
9 publications found
Genes affected
GYS2 (HGNC:4707): (glycogen synthase 2) The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content. [provided by RefSeq, Dec 2009]
GYS2 Gene-Disease associations (from GenCC):
- glycogen storage disorder due to hepatic glycogen synthase deficiencyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 12-21559611-A-G is Benign according to our data. Variant chr12-21559611-A-G is described in ClinVar as Benign. ClinVar VariationId is 261464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.777 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GYS2 | NM_021957.4 | c.1229+40T>C | intron_variant | Intron 9 of 15 | ENST00000261195.3 | NP_068776.2 | ||
| GYS2 | XM_024448960.2 | c.1229+40T>C | intron_variant | Intron 9 of 16 | XP_024304728.1 | |||
| GYS2 | XM_006719063.4 | c.998+40T>C | intron_variant | Intron 8 of 14 | XP_006719126.1 | |||
| GYS2 | XM_017019245.3 | c.*608T>C | downstream_gene_variant | XP_016874734.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GYS2 | ENST00000261195.3 | c.1229+40T>C | intron_variant | Intron 9 of 15 | 1 | NM_021957.4 | ENSP00000261195.2 | |||
| ENSG00000285854 | ENST00000647960.1 | n.*1231+40T>C | intron_variant | Intron 16 of 22 | ENSP00000497202.1 | |||||
| ENSG00000285854 | ENST00000648372.1 | n.1156+40T>C | intron_variant | Intron 9 of 10 |
Frequencies
GnomAD3 genomes AF: 0.746 AC: 113447AN: 152066Hom.: 42588 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
113447
AN:
152066
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.768 AC: 188577AN: 245472 AF XY: 0.769 show subpopulations
GnomAD2 exomes
AF:
AC:
188577
AN:
245472
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.765 AC: 683364AN: 893168Hom.: 262213 Cov.: 12 AF XY: 0.766 AC XY: 358796AN XY: 468236 show subpopulations
GnomAD4 exome
AF:
AC:
683364
AN:
893168
Hom.:
Cov.:
12
AF XY:
AC XY:
358796
AN XY:
468236
show subpopulations
African (AFR)
AF:
AC:
15408
AN:
23224
American (AMR)
AF:
AC:
34140
AN:
43652
Ashkenazi Jewish (ASJ)
AF:
AC:
15580
AN:
22566
East Asian (EAS)
AF:
AC:
29132
AN:
37098
South Asian (SAS)
AF:
AC:
58476
AN:
74278
European-Finnish (FIN)
AF:
AC:
42571
AN:
52966
Middle Eastern (MID)
AF:
AC:
2893
AN:
4600
European-Non Finnish (NFE)
AF:
AC:
454473
AN:
593238
Other (OTH)
AF:
AC:
30691
AN:
41546
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
6970
13939
20909
27878
34848
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
7410
14820
22230
29640
37050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.746 AC: 113542AN: 152184Hom.: 42625 Cov.: 33 AF XY: 0.749 AC XY: 55739AN XY: 74402 show subpopulations
GnomAD4 genome
AF:
AC:
113542
AN:
152184
Hom.:
Cov.:
33
AF XY:
AC XY:
55739
AN XY:
74402
show subpopulations
African (AFR)
AF:
AC:
28118
AN:
41522
American (AMR)
AF:
AC:
11348
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
2389
AN:
3470
East Asian (EAS)
AF:
AC:
3897
AN:
5184
South Asian (SAS)
AF:
AC:
3834
AN:
4822
European-Finnish (FIN)
AF:
AC:
8576
AN:
10598
Middle Eastern (MID)
AF:
AC:
180
AN:
294
European-Non Finnish (NFE)
AF:
AC:
53175
AN:
67982
Other (OTH)
AF:
AC:
1448
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1511
3022
4532
6043
7554
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
858
1716
2574
3432
4290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2613
AN:
3470
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Glycogen storage disorder due to hepatic glycogen synthase deficiency Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.